| Line item | 2025-12-28 FY | 2024-12-29 FY | 2023-12-31 FY | 2022-12-25 FY | 2021-12-26 FY |
|---|---|---|---|---|---|
| Revenue | $5.37B | $4.75B | $5.00B | $5.86B | $6.42B |
| Cost of Revenue | $1.30B | $1.18B | $1.71B | $1.91B | $1.93B |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $385.60M | $294.10M | $306.90M | $307.90M | $315.70M |
| SG&A | $1.17B | $1.21B | $1.48B | $1.67B | $1.43B |
| Operating Income | $11.10M | $690.00M | -$1.54B | $407.70M | $763.30M |
| Interest Expense | – | – | $186.30M | $171.00M | $179.70M |
| Tax Expense | $216.20M | $102.60M | -$221.30M | $58.50M | $146.60M |
| Net Income | -$322.40M | $385.60M | -$1.49B | $203.50M | $428.70M |
| EPS (basic) | -2.3000 | 2.7700 | -10.7300 | 1.4700 | 3.1100 |
| EPS (diluted) | -2.3000 | 2.7500 | -10.7300 | 1.4600 | 3.1000 |
| Shares (diluted) | $140.20M | $140.30M | $138.80M | $138.90M | $138.40M |